Evidence-based guideline summary: Evaluation, diagnosis, and management of congenital muscular dystrophy Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Issues Review Panel of the American Association of Neuromuscular & Electrodiagnostic Medicine
Peter B Kang, Leslie Morrison, Susan T Iannaccone, Robert J Graham, Carsten G Boennemann, Anne Rutkowski, Joseph Hornyak, Ching H Wang, Kathryn North, Maryam Oskoui, Thomas SD Getchius, Julie A Cox, Erin E Hagen, Gary Gronseth, Robert C Griggs
NEUROLOGY | LIPPINCOTT WILLIAMS & WILKINS | Published : 2015
OBJECTIVE: To delineate optimal diagnostic and therapeutic approaches to congenital muscular dystrophy (CMD) through a systematic review and analysis of the currently available literature. METHODS: Relevant, peer-reviewed research articles were identified using a literature search of the MEDLINE, EMBASE, and Scopus databases. Diagnostic and therapeutic data from these articles were extracted and analyzed in accordance with the American Academy of Neurology classification of evidence schemes for diagnostic, prognostic, and therapeutic studies. Recommendations were linked to the strength of the evidence, other related literature, and general principles of care. RESULTS: The geographic and ethn..View full abstract
Awarded by Centers for Disease Control and Prevention
Awarded by NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
Funding for this publication was made possible (in part) by grant DD10-1012 from the Centers for Disease Control and Prevention. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. The remaining funding was provided by the American Academy of Neurology.